24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
CVC Capital Partners
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:25
“I can retire… with peace”: Nir Zuk says Palo Alto Networks finally achieved his 20-year vision with $25B CyberArk acquisition
13:58
Intel VP: "Historically, if we were to miss milestones... we usually just gave exemptions. Saying no is a pretty powerful tool"
13:35
“We’re already living in a world where AI is attacking AI”
13:33
“In many cases the first market should not be America”
More stories
Buzz
Most popular
Daily
Weekly
1
Johny Srouji weighs leaving Apple, raising stakes for the Israeli executive who built its silicon program
2
“Other countries have air-defense systems, but Israel’s are better”: Arrow 3 lands in Germany as Israel pursues new mega deals
3
Could Prompt Security be SentinelOne’s lifeline as shares slide 35% this year?
4
ZIM faces pivotal vote as company weighs at least three acquisition offers
5
“I can retire… with peace”: Nir Zuk says Palo Alto Networks finally achieved his 20-year vision with $25B CyberArk acquisition
More news
CVC Capital Partners
3 stories about CVC Capital Partners
Cybersecurity Company Skybox Raises $150 Million
25.10.17
|
Hagar Ravet
Last year Rhode Island-based Providence Equity Partners bought a 75% stake in the company for $96 million
CVC in Advanced Talks to Buy Stake in Drugstore Chain Super-Pharm
24.09.17
|
Golan Hazani
The deal discussed gives Super-Pharm a $540 million value. The Israel drugstore chain operates in markets complementing CVC’s acquisition of Zabaka Polska
Teva Sells Remaining Women's Health Assets
18.09.17
|
Lilach Baumer
After selling its Paragard business for $1.1 billion last week, Teva's remaining Women's Health business will be split between CVC Capital Partners and Foundation Consumer Healthcare in a $1.38 billion cash deal